Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
6xUWL4yVZxHnb3Sh